Literature DB >> 9252191

Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion.

Y Wang1, M Okamoto, F Schmitz, K Hofmann, T C Südhof.   

Abstract

Rab3 is a neuronal GTP-binding protein that regulates fusion of synaptic vesicles and is essential for long-term potentiation of hippocampal mossy fibre synapses. More than thirty Rab GTP-binding proteins are known to function in diverse membrane transport pathways, although their mechanisms of action are unclear. We have now identified a putative Rab3-effector protein called Rim. Rim is composed of an amino-terminal zinc-finger motif and carboxy-terminal PDZ and C2 domains. It binds only to GTP (but not to GDP)-complexed Rab3, and interacts with no other Rab protein tested. There is enrichment of Rab3 and Rim in neurons, where they have complementary distributions. Rab3 is found only on synaptic vesicles, whereas Rim is localized to presynaptic active zones in conventional synapses, and to presynaptic ribbons in ribbon synapses. Transfection of PC12 cells with the amino-terminal domains of Rim greatly enhances regulated exocytosis in a Rab3-dependent manner. We propose that Rim serves as a Rab3-dependent regulator of synaptic-vesicle fusion by forming a GTP-dependent complex between synaptic plasma membranes and docked synaptic vesicles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252191     DOI: 10.1038/41580

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  209 in total

1.  An unusual C(2)-domain in the active-zone protein piccolo: implications for Ca(2+) regulation of neurotransmitter release.

Authors:  S H Gerber; J Garcia; J Rizo; T C Südhof
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Doc2 is not associated with known regulated exocytotic or endosomal compartments in adrenal chromaffin cells.

Authors:  N Charvin; G Williams; R D Burgoyne
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

3.  Identification of a putative effector protein for rab11 that participates in transferrin recycling.

Authors:  J Zeng; M Ren; D Gravotta; C De Lemos-Chiarandini; M Lui; H Erdjument-Bromage; P Tempst; G Xu; T H Shen; T Morimoto; M Adesnik; D D Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 4.  Protein-protein interactions and protein modules in the control of neurotransmitter release.

Authors:  F Benfenati; F Onofri; S Giovedí
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-02-28       Impact factor: 6.237

5.  The exocyst is an effector for Sec4p, targeting secretory vesicles to sites of exocytosis.

Authors:  W Guo; D Roth; C Walch-Solimena; P Novick
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

6.  A post-docking role for active zone protein Rim.

Authors:  S P Koushika; J E Richmond; G Hadwiger; R M Weimer; E M Jorgensen; M L Nonet
Journal:  Nat Neurosci       Date:  2001-10       Impact factor: 24.884

7.  Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels.

Authors:  Yoshitsugu Uriu; Shigeki Kiyonaka; Takafumi Miki; Masakuni Yagi; Satoshi Akiyama; Emiko Mori; Akito Nakao; Aaron M Beedle; Kevin P Campbell; Minoru Wakamori; Yasuo Mori
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

8.  Active zone density is conserved during synaptic growth but impaired in aged mice.

Authors:  Jie Chen; Takafumi Mizushige; Hiroshi Nishimune
Journal:  J Comp Neurol       Date:  2012-02-01       Impact factor: 3.215

Review 9.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

10.  RIM1alpha and RIM1beta are synthesized from distinct promoters of the RIM1 gene to mediate differential but overlapping synaptic functions.

Authors:  Pascal S Kaeser; Hyung-Bae Kwon; Chiayu Q Chiu; Lunbin Deng; Pablo E Castillo; Thomas C Südhof
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.